Clinical Trial Update: Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 trial of AL-2178 (FID 109980) for dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• AL-2178 (FID 109980)

Snippet

Sponsor: Alcon Research | Conditions: Dry Eye | Phase 3 | Status: COMPLETED